Organization

Centre for Molecular Oncology, University of New South Wales

2 abstracts

Abstract
Atezolizumab in patients (pts) with tumor mutational burden (TMB)–high tumors from the TAPISTRY trial.
Org: Medical University of Gdańsk, Gdańsk, Poland, International Centre for Thoracic Cancers (CICT), Gustave Roussy Cancer Center, Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine,
Abstract
Impact of artificial intelligence (AI) decision support on clinical trial participation: A before-after implementation study on a nationwide molecular tumor board.
Org: NHMRC Clinical Trials Centre, The University of Sydney, Garvan Institute of Medical Research, Prince of Wales Hospital, The NHMRC Clinical Trials Centre,